Search - tctmd.com

Displaying 161 - 172 of 172

Sort: Relevancy | Date

Presentation TCT 2012

DVT of the Upper Extremity: When and How to Initiate Pharmacologic and Mechanical Modes of Therapy

Presenter: Greg Mishkel

October 22, 2012

Presentation TCT 2012

Debate I. Is a Strategy of Endovascular Thrombus Resolution Best for Iliofemoral DVT? Pro!

Presenter: Anthony Comerota

October 22, 2012

Presentation TCT 2012

Methods for Successful Endovascular Management of Iliofemoral DVT

Presenter: Robert Lookstein

October 22, 2012

Presentation TCT 2012

Debate I. Is a Strategy of Endovascular Thrombus Resolution Best for Iliofemoral DVT? Con!

Presenter: Erich Minar

October 22, 2012

Presentation VEINS 2012

Rationale for a Strategy of Thrombus Removal for Patients with Iliofemoral DVT

Presenter: Anthony J. Comerota

September 15, 2012

Presentation VEINS 2012

CTV, MRV in Diagnosis of DVT: Where and When

Presenter: Mahmood Razavi

September 14, 2012

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

Yael L. Maxwell

December 12, 2011

News Industry News

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

September 08, 2011

News Daily News

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Caitlin E. Cox

May 06, 2011

News Industry News

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

January 04, 2011

Advertisement

DVT of the Upper Extremity: When and How to Initiate Pharmacologic and Mechanical Modes of Therapy

Debate I. Is a Strategy of Endovascular Thrombus Resolution Best for Iliofemoral DVT? Pro!

Methods for Successful Endovascular Management of Iliofemoral DVT

Debate I. Is a Strategy of Endovascular Thrombus Resolution Best for Iliofemoral DVT? Con!

Rationale for a Strategy of Thrombus Removal for Patients with Iliofemoral DVT

CTV, MRV in Diagnosis of DVT: Where and When

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

Catheter-Directed Thrombolysis Beneficial for Proximal DVT

FDA Advisory Committee Recommends Approval of Oral Anticoagulant Rivaroxaban for the Prevention of Stroke and Systemic Embolism in Patients with Non-Valvular Atrial Fibrillation

Study Hints Stenting Tops Angioplasty Alone for Stubborn DVT

Bayer’s Rivaroxaban Submitted for EU Marketing Authorisation in Stroke Prevention in Patients with Atrial Fibrillation as well as for the Treatment of Deep Vein Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content